default author photo

Partow Kebriaei

University of Texas at Houston - MD Anderson Cancer Center

1901 East Road, Unit 1950

Unit 1905

Houston, TX 77030

United States

SCHOLARLY PAPERS

4

DOWNLOADS

325

TOTAL CITATIONS

2

Scholarly Papers (4)

1.

A Phase 3 Study of Remestemcel-L versus Placebo Added to Second Line Therapy in Patients with Steroid Refractory Acute Graft Versus Host Disease

Number of pages: 31 Posted: 19 Mar 2019
University of Texas at Houston - MD Anderson Cancer Center, Mesoblast, University of Calgary - Tom Baker Cancer Center, Karmanos Cancer Institute, University Hospitals Bristol, Harvard University - Dana-Farber Cancer Institute, Emory University - Emory University Hospital, Mesoblast, Mesoblast, University of Texas at Houston - MD Anderson Cancer Center and Fred Hutchinson Cancer Research Center
Downloads 156 (477,517)
Citation 2

Abstract:

Loading...

mesenchymal stem cells, acute graft-versus-host disease, allogeneic hematopoietic cell transplantation

2.

Results of Salvage Therapy with Mini-Hyper-CVD and Inotuzumab Ozogamicin with or Without Blinatumomab in Pre-B Acute Lymphoblastic Leukemia

Number of pages: 45 Posted: 06 Dec 2022
University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Hematopathology, University of Texas at Houston - Department of Hematopathology, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Pharmacy, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Radiation Oncology, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of California, Irvine - Chao Family Comprehensive Cancer Center, University of Texas at Houston - Department of Leukemia and University of Texas at Houston - Department of Leukemia
Downloads 73 (860,052)

Abstract:

Loading...

Philadelphia-negative ALL, inotuzumab, blinatumomab, chemo-immunotherapy, salvage, outcome

3.

Safety and Efficacy of a New High-Dose Chemotherapy Regimen of Panobinostat, Gemcitabine, Busulfan and Melphalan for 1st or 2nd Salvage Autologous Stem Cell Transplant for Patients with Refractory/Relapsed or High-Risk Myeloma: Matched Pair Comparisons with Concurrent Control Cohorts

Number of pages: 33 Posted: 10 Aug 2023
University of Texas at Houston - Department of Biostatistics, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Stem Cell Transplantation and Cellular Therapy, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Stem Cell Transplantation and Cellular Therapy, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center and University of Texas at Houston - MD Anderson Cancer Center
Downloads 72 (860,052)

Abstract:

Loading...

Myeloma, autologous stem-cell transplant, high-dose chemotherapy, phase 2 trial, matched pair comparison

4.

Treatment in Clinical Trials Could Mitigate Socioeconomic and Racial Disparities in Acute Myeloid Leukemia

Number of pages: 37 Posted: 27 Apr 2026
University of Texas at Houston - Department of Leukemia, University of Texas at Houston - MD Anderson Cancer Center, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, affiliation not provided to SSRN, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, affiliation not provided to SSRN, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, affiliation not provided to SSRN, University of Texas at Houston - Department of Leukemia, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Texas at Houston - Department of Biostatistics, affiliation not provided to SSRN, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Stem Cell Transplantation and Cellular Therapy, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Leukemia and University of Texas at Houston - Department of Leukemia
Downloads 24 (1,411,822)

Abstract:

Loading...

Area deprivation index, racial/ethnic disparity, clinical trials, stem cell transplant